Healthlead PCL (BKK:HL)
Thailand · Delayed Price · Currency is THB 4.480
-0.020 (-0.44%)
Sep 11, 2026, 4:36 PM ICT
Healthlead PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,142 | 1,886 | 2,774 | 2,829 | 6,691 | 4,923 | |
Market Cap Growth | -43.96% | -32.02% | -1.92% | -57.72% | 35.91% | - |
Enterprise Value | 1,023 | 1,683 | 2,538 | 2,463 | 6,185 | 5,050 |
Last Close Price | 4.50 | 6.97 | 9.64 | 9.70 | 22.77 | 16.62 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.72 | 24.22 | 35.45 | 37.88 | 56.60 | 61.80 |
Forward PE | - | 24.84 | 24.84 | 16.07 | 48.24 | - |
PS Ratio | 0.50 | 0.83 | 1.38 | 1.71 | 4.35 | 4.05 |
PB Ratio | 1.30 | 1.95 | 2.76 | 2.92 | 7.10 | 5.69 |
P/TBV Ratio | 1.34 | 2.00 | 2.83 | 2.99 | 7.28 | 5.85 |
P/FCF Ratio | 11.98 | 11.71 | 195.40 | 290.88 | 416.41 | 67.96 |
P/OCF Ratio | 9.54 | 9.76 | 31.26 | 31.00 | 49.13 | 57.75 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.45 | 0.74 | 1.26 | 1.48 | 4.02 | 4.15 |
EV/EBITDA Ratio | 5.47 | 10.97 | 19.33 | 19.50 | 37.96 | 43.12 |
EV/EBIT Ratio | 11.45 | 15.23 | 26.61 | 24.45 | 41.68 | 49.20 |
EV/FCF Ratio | 10.73 | 10.45 | 178.77 | 253.25 | 384.92 | 69.72 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.33 | 0.33 | 0.30 | 0.23 | 0.18 | 0.14 |
Debt / EBITDA Ratio | 1.56 | 1.57 | 1.74 | 1.44 | 0.90 | 0.89 |
Debt / FCF Ratio | 3.06 | 1.98 | 20.88 | 23.07 | 10.41 | 1.63 |
Net Debt / Equity Ratio | -0.14 | -0.24 | -0.22 | -0.34 | -0.52 | -0.68 |
Net Debt / EBITDA Ratio | -0.87 | -1.50 | -1.68 | -2.64 | -2.98 | -5.01 |
Net Debt / FCF Ratio | -1.25 | -1.43 | -15.50 | -34.30 | -30.24 | -8.10 |
Asset Turnover | 1.57 | 1.50 | 1.40 | 1.24 | 1.28 | 1.59 |
Inventory Turnover | 4.97 | 5.62 | 5.79 | 5.69 | 6.19 | 6.36 |
Quick Ratio | 1.84 | 2.23 | 2.65 | 2.99 | 3.62 | 5.03 |
Current Ratio | 3.34 | 3.40 | 4.05 | 4.26 | 4.76 | 6.15 |
Return on Equity (ROE) | 6.44% | 7.89% | 7.93% | 7.82% | 13.08% | 15.83% |
Return on Assets (ROA) | 3.87% | 4.55% | 4.14% | 4.71% | 7.71% | 8.37% |
Return on Invested Capital (ROIC) | 9.52% | 11.48% | 10.90% | 14.67% | 33.43% | 32.08% |
Return on Capital Employed (ROCE) | 7.80% | 8.70% | 7.40% | 8.50% | 13.50% | 10.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.20% | 4.13% | 2.82% | 2.64% | 1.77% | 1.62% |
FCF Yield | 8.35% | 8.54% | 0.51% | 0.34% | 0.24% | 1.47% |
Dividend Yield | 4.76% | 3.16% | 1.76% | 1.55% | 0.79% | 1.69% |
Payout Ratio | 95.29% | 59.39% | 52.13% | 65.56% | 36.81% | 47.70% |
Buyback Yield / Dilution | 3.99% | 1.29% | - | - | -31.84% | -27.46% |
Total Shareholder Return | 8.75% | 4.45% | 1.76% | 1.55% | -31.05% | -25.78% |